ISBAMEDIUM SIGNALFINANCIAL10-K

Isabella Bank Corporation shows solid operational improvements with notably higher net income, operating cash flow, and increased capital investment activity.

The bank demonstrates healthy profitability growth with net income expanding meaningfully alongside stronger operating cash generation, suggesting improved operational efficiency. The company is simultaneously investing more heavily in capital expenditures and returning additional cash to shareholders through expanded buyback programs, indicating management confidence in the business trajectory.

Comparing 2026-03-13 vs 2025-03-12View on EDGAR →
FINANCIAL ANALYSIS

Isabella Bank delivered strong financial performance with net income growing substantially to $18.9M and operating cash flow reaching $26.8M, both representing solid increases from the prior year. The bank meaningfully expanded its capital expenditure program while also increasing share buybacks, demonstrating both growth investment and shareholder capital return priorities. Stockholders' equity grew modestly to $231.4M, reflecting the balance between retained earnings growth and capital distributions.

FINANCIAL STATEMENT CHANGES
Capital Expenditure
Cash Flow
+65.2%
$2.1M$3.5M

Capital expenditure jumped 65.2% — major investment cycle underway; assess returns on deployment.

Share Buybacks
Cash Flow
+53.1%
$3.1M$4.7M

Share repurchases increased 53.1% — management returning capital, signals confidence in intrinsic value.

Operating Cash Flow
Cash Flow
+36.6%
$19.6M$26.8M

Operating cash flow surged 36.6% — exceptional cash generation, highest quality earnings signal.

Net Income
P&L
+36.2%
$13.9M$18.9M

Net income grew 36.2% — bottom-line growth signals improving overall business health.

Stockholders Equity
Balance Sheet
+10%
$210.3M$231.4M

Equity base grew 10% — retained earnings accumulation or equity issuance strengthening the balance sheet.

LANGUAGE CHANGES
NEW — 2026-03-13
PRIOR — 2025-03-12
ADDED
The number of common shares outstanding of the registrant s Common Stock (no par value) was 7,330,036 as of March 12, 2026.
The Isabella Bank Corporation Proxy Statement will be mailed on or before March 23, 2026.
ACL: Allowance for credit losses FRB: Board of Governors of the Federal Reserve System AFS: Available-for-sale Freddie Mac: Federal Home Loan Mortgage Corporation ALCO: Asset-Liability Committee FTE: Fully taxable equivalent ALLL: Allowance for loan and lease losses GAAP: U.S.
These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance.
These statements are often, but not always, made through the use of words or phrases such as may, might, should, could, predict, potential, believe, expect, continue, will, likely, anticipate, seek, estimate, intend, plan, strive, projection, goal, target, aim, would, annualized and outlook, or the negative version of those words or other comparable words or phrases of a future or forward-looking nature.
+7 more — sign up free →
REMOVED
The number of common shares outstanding of the registrant s Common Stock (no par value) was 7,414,594 as of March 11, 2025.
The Isabella Bank Corporation Proxy Statement will be mailed on or before March 25, 2025.
Form 10-K Summary 94 SIGNATURES 95 2 Ta ble of Contents Glossary of Acronyms and Abbreviations The acronyms and abbreviations identified below may be used throughout this Annual Report on Form 10-K or in our other SEC filings.
ACL: Allowance for credit losses FTE: Fully taxable equivalent AFS: Available-for-sale GAAP: U.S.
Securities and Exchange Commission FFIEC: Federal Financial Institutions Examinations Council SOX: Sarbanes-Oxley Act of 2002 FHLB: Federal Home Loan Bank XBRL: eXtensible Business Reporting Language FRB: Federal Reserve Bank Yield Curve: U.S.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →